BAC
Bank of America Corporation
BAC offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
FGN
F&G Annuities & Life, Inc.
FGN has the edge over BAC overall, supported by stronger modeled upside and stronger valuation.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
FGN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Strong | |
| N/A | |
| N/A |
FGN's profitability is currently strong, but its revenue is under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like FGN.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
FGN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 2.9x | $21.86 | — |
| Forward | 3.6x | $21.86 | — |
| Cheap | 6.4x | $49.03 | +124% |
| Fair | 7.6x | $57.60 | +164% |
| Expensive | 11x | $81.59 | +273% |
Historical ranges are pointers, not guarantees.
FGN has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over FGN on the outlook, with more favorable valuation and revenue expectations.
FGN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect FGN's earnings to grow and its profitability to improve, with its revenue holding steady.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over FGN on earnings, with more consistent year-over-year improvement.
FGN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.14 | -19% |
| Q3 2026 | $7.61 | +121% |
| Q2 2026 | $2.98 | +19% |
| Q1 2026 | $3.86 | +1.6% |
| Q4 2025 | $1.88 | -61% |
| Q3 2025 | $3.44 | +$3.49 |
| Q2 2025 | $2.51 | +1.2% |
| Q1 2025 | $3.80 | +93% |
| Q4 2024 | $4.88 | +$5.35 |
FGN's earnings per share have fallen from their peak: $7.61 over the past year, against $10.61 in mid-2022.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over FGN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
FGN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.1B | -33% |
| Q2 2026 | $1.4B | +4.2% |
| Q1 2026 | $1.2B | +31% |
| Q4 2025 | $1.8B | +13% |
| Q3 2025 | $1.7B | +17% |
| Q2 2025 | $1.4B | +16% |
| Q1 2025 | $908M | -42% |
| Q4 2024 | $1.6B | -3.3% |
FGN's revenue has held roughly level: $1.1B last quarter, down 33% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2022 | 93% | -5.1 points |
| Q3 2022 | 25% | -72 points |
| Q2 2022 | 55% | -40 points |
| Q1 2022 | 96% | +0.6 points |
| Q4 2021 | 98% | N/A |
| Q3 2021 | 97% | +47 points |
| Q2 2021 | 95% | +81 points |
| Q1 2021 | 95% | +82 points |
FGN's operating margin was 93% last quarter, down 5.1 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over FGN on cash flow, with more consistent year-over-year improvement.
FGN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $982M | +4.8% |
| Q2 2026 | $1.5B | -8.2% |
| Q1 2026 | $743M | -22% |
| Q4 2025 | $1.2B | -12% |
| Q3 2025 | $937M | -55% |
| Q2 2025 | $1.6B | +54% |
| Q1 2025 | $956M | -38% |
| Q4 2024 | $1.3B | -41% |
FGN's free cash flow was $4.4B over the past year, down 9.4% from the year before. Free cash flow isn't a meaningful measure for financial services companies like FGN.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over FGN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
FGN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.8% | +5M shares |
| 1 year | -2.9% | -4M shares |
| 3 years | +8% | +10M shares |
| 5 years | +29% | +30M shares |
| Available history | -39% | -84.7M shares |
FGN has 135M diluted shares, down 2.9% from a year ago, with $130M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $94M |
| Q1 2026 | $29M |
| Q4 2025 | $7M |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $3M |
| Q4 2024 | $6M |
FGN spent $130M buying back its own shares over the past year, more than ten times what it spent the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
FGN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2022 | 0.4x | Very low |
| Q4 2021 | -90.3x | Net Cash |
| Q3 2019 | -7.9x | Net Cash |
| Q2 2019 | -5.9x | Net Cash |
| Q1 2019 | -19.9x | Net Cash |
FGN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago. Net leverage isn't a meaningful measure for financial services companies like FGN.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
FGN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.3 | Oversold |
| Stochastic | 9.6 | Oversold |
FGN's weekly RSI is 27 (oversold) and its Stochastic is 10 (oversold).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
FGN PE vs Financial Services Sector
| Metric | FGN | Sector median | Relative |
|---|---|---|---|
| PE | 2.9x | 13x | 78% below |
| PE % | 0 | 38 | 38 pts below |
FGN has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has stronger trend alignment. BAC is above 1 of 5 weekly averages versus FGN above 0 of 4.
FGN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $23.0 | 4.7% below |
| 20 week MA | $24.0 | 8.8% below |
| 50 week MA | $24.7 | 11% below |
| 100 week MA | $25.5 | 14% below |
FGN is in a downtrend: it's below all four of its weekly moving averages, and 14% below its 100-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over FGN on returns for 2026, with the stronger performance.
FGN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $25.9 | $25.8 | -0.3% |
| 2024 | $25.8 | $26.5 | +2.5% |
| 2025 | $26.5 | $25.5 | -3.7% |
| 2026 YTD | $25.5 | $21.9 | -14% |
FGN has finished lower in two of the last three years. It's down 14% so far in 2026.